Retraction Notice to “Ketamine Reduces LPS-Induced HMGB1 Through HO-1 and Nrf2/ p38 MAPK” [Journal of Surgical Research 194 (2015) 599-613] (Journal of Surgical Research (2015) 194(599-613) (S002248041401066X), (10.1016/j.jss.2014.11.031));Ketamine reduces lipopolysaccharide-induced high-mobility group box-1 through heme oxygenase-1 and nuclear factor erythroid 2-related factor 2/ p38 mitogen-activated protein kinase

Journal of Surgical Research

Volumn 194, Issue 2, 2015, Pages 599-613

  Wang, Fujun ^a   Meng, Yong ^a   Zhang, Yiwei ^a   Zhao, Guoguang ^a   Zheng, Xiaonan ^a   Xiao, Qifeng ^a   Yu, Yang ^b  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^b QINGDAO MUNICIPAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTIINFLAMMATORY AGENT; HEME OXYGENASE 1; HEME OXYGENASE INHIBITOR; HIGH MOBILITY GROUP B1 PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN ANTIBODY; INTERLEUKIN 1BETA; KETAMINE; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; PROTEIN ANTIBODY; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR NRF2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ZNPPIX; ANESTHETIC AGENT; HMGB1 PROTEIN, MOUSE; HMOX1 PROTEIN, MOUSE; MEMBRANE PROTEIN; NFE2L2 PROTEIN, MOUSE;

ACUTE LUNG INJURY; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY INFILTRATE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; SEPSIS; SIGNAL TRANSDUCTION; SURVIVAL; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; CELL LINE; CELL SURVIVAL; DISEASE MODEL; DRUG EFFECTS; LUNG; METABOLISM; SPRAGUE DAWLEY RAT;

ACUTE LUNG INJURY; ANESTHETICS, DISSOCIATIVE; ANIMALS; CELL LINE; CELL SURVIVAL; DISEASE MODELS, ANIMAL; HEME OXYGENASE-1; HMGB1 PROTEIN; KETAMINE; LIPOPOLYSACCHARIDES; LUNG; MALE; MAP KINASE SIGNALING SYSTEM; MEMBRANE PROTEINS; MICE; NF-E2-RELATED FACTOR 2; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS, SPRAGUE-DAWLEY; SEPSIS;

EID: 84924870731     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2020.06.002     Document Type: Erratum

References (48)

1. A. Oberholzer, C. Oberholzer, and L.L. Moldawer Sepsis syndromes: understanding the role of innate and acquired immunity Shock 16 2001 83
2. D. Landsman, and M. Bustin A signature for the HMG-1 box DNA-binding proteins Bioessays 15 1993 539
3. U. Andersson, H. Wang, and K. Palmblad High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes J Exp Med 192 2000 565
4. J.S. Park, D. Svetkauskaite, and Q. He Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein J Biol Chem 279 2004 7370
5. A. Rouhiainen, S. Tumova, L. Valmu, N. Kalkkinen, and H. Rauvala Pivotal advance: analysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (amphoterin) J Leukoc Biol 81 2007 49
6. Q. Yang, X. Liu, Z. Yao, S. Mao, Q. Wei, and Y. Chang Penehyclidine hydrochloride inhibits the release of high-mobility group box 1 in lipopolysaccharide-activated RAW264.7 cells and cecal ligation and puncture-induced septic mice J Surg Res 186 2014 310
7. D. Tang, R. Kang, and W. Xiao Quercetin prevents LPS-induced high-mobility group box 1 release and proinflammatory function Am J Respir Cell Mol Biol 41 2009 651
8. H.T. Chung, H.O. Pae, and Y.N. Cha Role of heme oxygenase-1 in vascular disease Curr Pharm Des 14 2008 422
9. J.M. Lee, J. Li, and D.A. Johnson Nrf2, a multi-organ protector? Faseb J 19 2005 1061
10. K.J. Min, M.S. Yang, S.U. Kim, I. Jou, and E.H. Joe Astrocytes induce hemeoxygenase-1 expression in microglia: a feasible mechanism for preventing excessive brain inflammation J Neurosci 26 2006 1880
11. P.J. Syapin Regulation of haeme oxygenase-1 for treatment of neuroinflammation and brain disorders Br J Pharmacol 155 2008 623
12. F.L. Liu, T.L. Chen, and R.M. Chen Mechanisms of ketamine-induced immunosuppression Acta Anaesthesiol Taiwan 50 2012 172
13. C.M. Tsao, and C.C. Wu Modulating effects of ketamine on inflammatory response in sepsis Acta Anaesthesiol Taiwan 50 2012 145
14. X. Zhang, J. Feng, P. Zhu, and Z. Zhao Ketamine inhibits calcium elevation and hydroxyl radical and nitric oxide production in lipopolysaccharide-stimulated NR8383 alveolar macrophages Inflammation 36 2013 1094
15. N. Hatakeyama, and N. Matsuda Mechanisms of inflammatory response and organ dysfunction: organ-protective strategy by anesthetics Curr Pharm Des 20 2014 5766
16. Y. Chang, J.J. Lee, C.Y. Hsieh, G. Hsiao, D.S. Chou, and J.R. Sheu Inhibitory effects of ketamine on lipopolysaccharide-induced microglial activation Mediators Inflamm 2009 2009 705379
17. H.W. Lu, G.N. He, H. Ma, and J.K. Wang Ketamine reduces inducible superoxide generation in human neutrophils in vitro by modulating the p38 mitogen-activated protein kinase (MAPK)-mediated pathway Clin Exp Immunol 160 2010 450
18. J.W. Suliburk, J.L. Ward, K.S. Helmer, S.D. Adams, B.S. Zuckerbraun, and D.W. Mercer Ketamine-induced hepatoprotection: the role of heme oxygenase-1 Am J Physiol Gastrointest Liver Physiol 296 2009 G1360
19. J.W. Suliburk, E.A. Gonzalez, S.D. Kennison, K.S. Helmer, and D.W. Mercer Differential effects of anesthetics on endotoxin-induced liver injury J Trauma 58 2005 711
20. H.G. Chen, K.L. Xie, and H.Z. Han Heme oxygenase-1 mediates the anti-inflammatory effect of molecular hydrogen in LPS-stimulated RAW 264.7 macrophages Int J Surg 11 2013 1060
21. E.J. Park, H.J. Jang, and K. Tsoyi The heme oxygenase-1 inducer THI-56 negatively regulates iNOS expression and HMGB1 release in LPS-activated RAW 264.7 cells and CLP-induced septic mice PloS One 8 2013 e76293
22. H.J. Jang, Y.M. Kim, and K. Tsoyi Ethyl pyruvate induces heme oxygenase-1 through p38 mitogen-activated protein kinase activation by depletion of glutathione in RAW 264.7 cells and improves survival in septic animals Antioxid Redox Signal 17 2012 878
23. D. Lee, J. Bae, and Y.K. Kim Inhibitory effects of berberine on lipopolysaccharide-induced inducible nitric oxide synthase and the high-mobility group box 1 release in macrophages Biochem Biophys Res Commun 431 2013 506
24. H.S. Kim, E.J. Park, S.W. Park, H.J. Kim, and K.C. Chang A tetrahydroisoquinoline alkaloid THI-28 reduces LPS-induced HMGB1 and diminishes organ injury in septic mice through p38 and PI3K/Nrf2/HO-1 signals Int Immunopharmacol 17 2013 684
25. E.H. Carchman, J. Rao, P.A. Loughran, M.R. Rosengart, and B.S. Zuckerbraun Heme oxygenase-1-mediated autophagy protects against hepatocyte cell death and hepatic injury from infection/sepsis in mice Hepatology 53 2011 2053
26. K. Suda, Y. Kitagawa, and S. Ozawa Anti-high-mobility group box chromosomal protein 1 antibodies improve survival of rats with sepsis World J Surg 30 2006 1755
27. Y. Chang, X. Huang, and Z. Liu Dexmedetomidine inhibits the secretion of high mobility group box 1 from lipopolysaccharide-activated macrophages in vitro J Surg Res 181 2013 308
28. T. Yuan, Z. Li, X. Li, G. Yu, N. Wang, and X. Yang Lidocaine attenuates lipopolysaccharide-induced inflammatory responses in microglia J Surg Res 15 2014 00463
29. Y. Ge, S. Hu, and Y. Zhang Levobupivacaine inhibits lipopolysaccharide-induced high mobility group box 1 release in vitro and in vivo J Surg Res 4 2014 00550
30. T.D. Schmittgen, and K.J. Livak Analyzing real-time PCR data by the comparative C(T) method Nat Protoc 3 2008 1101
31. Z. Liu, J. Zhang, X. Huang, L. Huang, S. Li, and Z. Wang Magnesium sulfate inhibits the secretion of high mobility group box 1 from lipopolysaccharide-activated RAW264.7 macrophages in vitro J Surg Res 179 2013 e189
32. Z. Liu, Y. Chang, and J. Zhang Magnesium deficiency promotes secretion of high-mobility group box 1 protein from lipopolysaccharide-activated macrophages in vitro J Surg Res 180 2013 310
33. K.S. Helmer, J.W. Suliburk, and D.W. Mercer Ketamine-induced gastroprotection during endotoxemia: role of heme-oxygenase-1 Dig Dis Sci 51 2006 1571
34. Y.C. Oh, Y.H. Jeong, W.K. Cho, M.J. Gu, and J.Y. Ma Inhibitory effects of Palmultang on inflammatory mediator production related to suppression of NF-kappaB and MAPK pathways and induction of HO-1 expression in macrophages Int J Mol Sci 15 2014 8443
35. A. Jadhav, E. Torlakovic, and J.F. Ndisang Interaction among heme oxygenase, nuclear factor-kappaB, and transcription activating factors in cardiac hypertrophy in hypertension Hypertension 52 2008 910
36. Y.A. Hong, J.H. Lim, and M.Y. Kim Delayed treatment with oleanolic acid attenuates tubulointerstitial fibrosis in chronic cyclosporine nephropathy through Nrf2/HO-1 signaling J Transl Med 12 2014 1479
37. C.Y. Li, T.C. Chou, and C.S. Wong Ketamine inhibits nitric oxide synthase in lipopolysaccharide-treated rat alveolar macrophages Can J Anaesth 44 1997 989
38. S.Y. Kwon, J.H. Yeom, and J.D. Joo Ketamine reduces the induced spinal p38 MAPK and pro-inflammatory cytokines in a neuropathic rats Korean J Anesthesiol 66 2014 52
39. P. Pan, J. Cardinal, and R. Dhupar Low-dose cisplatin administration in murine cecal ligation and puncture prevents the systemic release of HMGB1 and attenuates lethality J Leukoc Biol 86 2009 625
40. Y. Yang, S. Li, and Q. Yang Resveratrol reduces the proinflammatory effects and lipopolysaccharide-induced expression of HMGB1 and TLR4 in RAW264.7 cells Cell Physiol Biochem 33 2014 1283
41. X.J. Gu, J. Xu, and B.Y. Ma Effect of glycyrrhizin on traumatic brain injury in rats and its mechanism Chin J Traumatol 17 2014 1
42. E.F. Domino, E.K. Zsigmond, L.E. Domino, K.E. Domino, S.P. Kothary, and S.E. Domino Plasma levels of ketamine and two of its metabolites in surgical patients using a gas chromatographic mass fragmentographic assay Anesth Analg 61 1982 87
43. J. Wieber, R. Gugler, J.H. Hengstmann, and H.J. Dengler Pharmacokinetics of ketamine in man Anaesthesist 24 1975 260
44. J. Idvall, I. Ahlgren, K.R. Aronsen, and P. Stenberg Ketamine infusions: pharmacokinetics and clinical effects Br J Anaesth 51 1979 1167
45. T. Sakai, T. Ichiyama, C.W. Whitten, A.H. Giesecke, and J.M. Lipton Ketamine suppresses endotoxin-induced NF-kappaB expression Can J Anaesth 47 2000 1019
46. M. Yu, D. Shao, J. Liu, J. Zhu, Z. Zhang, and J. Xu Effects of ketamine on levels of cytokines, NF-kappaB and TLRs in rat intestine during CLP-induced sepsis Int Immunopharmacol 7 2007 1076
47. M. Yu, D. Shao, R. Yang, X. Feng, S. Zhu, and J. Xu Effects of ketamine on pulmonary inflammatory responses and survival in rats exposed to polymicrobial sepsis J Pharm Pharm Sci 10 2007 434
48. M. Yu, D. Shao, X. Feng, M. Duan, and J. Xu Effects of ketamine on pulmonary TLR4 expression and NF-kappa-B activation during endotoxemia in rats Methods Find Exp Clin Pharmacol 29 2007 395